CYLD and nasopharyngeal carcinoma: In NPC, persistent NF-kB pathway activation can be contributed by overexpression of LMP1 or through genetic alterations of NF-κB negative regulators (TRAF3, CYLD, NFKBI) and receptors (LTBR).